A roundup of the latest news about the omicron coronavirus.
Two COVID-19 cases caused by the omicron variant have been detected in Ontario, Canadian health officials announced Sunday, according to the Washington Post.
Whether the omicron variant is going to cause more serious disease is unclear, but COVID-19 patterns in South Africa are worrisome. The emergence of the variant has led to a spike in COVID-19 hospitalizations in the country’s Gauteng province—home to the capital city of Pretoria and Johannesburg. There were 49 hospitalizations during the two weeks that ended on Nov.27, compared with 18 in the two weeks prior, according to the Wall Street Journal.
The first known South African case of omicron was detected on Nov.11, the newspaper reported. Since, the daily number of cases nationwide has increased tenfold, from 300 to more than 3,000, the Journal reported.
In a technical brief to its member states, the World Health Organization (WHO) said the multiple mutations of the coronavirus spike protein mean there’s a “high likelihood” that the omicron variant will escape antibody-mediated defenses against infection. However, the international health organization also said in the Nov. 28 document that it was more difficult to predict whether the virus might slip by the defenses of the other arm of the immune system, called cell-mediated immunity. The WHO technical brief also gave some reassurance that despite the uncertainties about omicron “is it reasonable to assume that currently available vaccines off some protection against severe disease.”
As the WHO technical note makes clear, hopes that omicron can be controlled rest, in part, on the power of cell-medicated immunity, which includes T cells. A news story in Nature that was originally posted on Nov. 25 and then updated on Nov. 27 says, though, that hints from computer modeling of omicron by South African researchers suggest the variant may (there are more tests to be done) also maneuver around the cell-mediated arm of the immune response.
President Joe Biden announced on Friday that starting today most travelers from South Africa and seven other countries would not be allowed to enter the U.S. Many other countries have also moved quickly to impose travel bans, although there is debate about how effective they are in stopping the spread of what seems to be a highly transmissible variant of the coronavirus. Japan has gone further and closed off travel from everywhere, the New York Times reported this morning. “It is a familiar tactic for Japan,” the newspaper reported. “The country has barred tourists since early in the pandemic, even as most of the rest of the world started to travel again.”
The travel bans affecting South Africa and other countries in southern Africa could cause economic and other sorts of hardships. An editorial in the Observer, a British news publication, says “global compensation” for South Africa for being forthright about omicron might prevent other countries from keeping variant knowledge secret.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More